Symyx Launches Contract Development and Manufacturing Organization (CDMO) for Biopharmaceuticals
April 22, 2009
Leader in Microscale, Parallel Experimentation and Scientific Informatics Offers Integrated Contract Formulation Development and CGMP Fill and Finish Manufacturing SUNNYVALE, CA--Apr 22, 2009 -- Symyx Technologies, Inc. (NasdaqGS:SMMX - News) today announced the launch of the Symyx Contract Development and Manufacturing Organization (CDMO). The Symyx CDMO helps biopharmaceutical companies move promising drug candidates to clinical [...]
Cardiff University Becomes a GeneGo Center of Excellence
April 22, 2009
ST. JOSEPH, Mich., April 22 -- GeneGo, Inc., a leading provider of software and databases for systems biology and pathway analysis, today announced that the University of Cardiff has become a certified GeneGo Center of Excellence. Cardiff University researchers will have access to GeneGo's MetaCore, training and advanced support. They will be able to leverage [...]
Biotage is Subject to Patent Litigation in the US
April 22, 2009
STOCKHOLM, Sweden--Regulatory News: Biotage AB (STO:BIOTA) has together with its subsidiaries Biotage GB Ltd and Biotage LLC been sued for patent infringement in the U.S. District court for the Southern District of California. The lawsuit has been filed by Scientific Plastic Products, Inc. and concerns the US patents no 7,138,061, 7,381,327 and 7,410,571 each entitled [...]
Automatic Synthesis Monitoring via UV
April 22, 2009
Activotec has announced an exciting new development for it’s Activo-P11 Peptide Synthesizer, automatic UV monitoring of the Fmoc removal during solid phase synthesis with feedback to the synthesizer software. This allows the user to monitor the synthesis of peptides and to automatically change the deprotection and coupling protocols for each amino acid depending on the [...]
Molecular Sensing, Inc. and VIB Enter Agreement in Alzheimer’s Disease Research
April 22, 2009
Aims to Characterize Substrate Recognition Mechanism and Screen for Potential Drug Compounds that Inhibit Amyloid Build-up Montara, California, April 22, 2009 - Molecular Sensing, Inc. (MSI) today announced that it has entered into a Life Science Early Access Program (LEAP) research agreement with VIB to use MSI’s proprietary Back-Scattering Interferometry (BSI) technology to study ligand [...]
April 22, 2009
Enables End-to-End Process Streamlining and Full Traceability from Study Setup through Data Analysis and Submission WALTHAM, Mass.--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that it has acquired privately held Waban Software, a leading provider of platform solutions for the automation and compliance of [...]
April 21, 2009
Global leader in assay technology improves speed and sensitivity for detection of proteins associated with diseases Experimental Biology 2009 NEW ORLEANS--At Experimental Biology 2009, PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of Western BLAST™, an amplification system used to enhance and simplify [...]
VIASPACE Inc. to Demonstrate New Technology for Chemical, Explosive and Drug Detection
April 21, 2009
Under $786,000 Phase II Contract with U.S. Navy PASADENA, Calif., April 21 -- VIASPACE Inc. (OTC Bulletin Board: VSPC) an alternative energy company with subsidiary operations in security technology, is planning a mid-May 2009 field demonstration of its high-sensitivity system for detecting and analyzing chemical, explosive, and drug residues in suspect vessels. The demonstration is [...]
April 21, 2009
CARLSBAD, Calif.--Applied Biosystems, a division of Life Technologies Corporation (NASDAQ:LIFE), today unveiled new approaches for using next-generation genomic analysis sequencing to better understand methylation patterns in different cancerous disease states. A team of research and development scientists utilized the SOLiD™ System, an advanced genomic analysis technology, to characterize the methylation status of repetitive elements in [...]
Oscar-Werner Reif Becomes New Member of The Board of Sartorius Stedim Biotech S.A.
April 21, 2009
Annual General Shareholders’ Meeting appoints R&D Vice President to the top executive committee AUBAGNE, France & GOETTINGEN, Germany--The Annual General Shareholders’ Meeting of Sartorius Stedim Biotech S.A. (Paris:DIM) listed on the French stock exchange resolved today to appoint Dr. Oscar-Werner Reif as an additional member to the Board of Directors. By passing this resolution, the [...]
